Sanofi Leapfrogs Biocon To Land First US Rapid-Acting Insulin Biosimilar
French Firm’s Merilog Is First Insulin Approved Since 2021; FDA Eyes Improved Efficiency
Sanofi has bolstered its insulin offerings by bagging the first US FDA approval for a rapid-acting insulin aspart biosimilar, leaving several would-be sponsors in its wake.
